查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1819918

2025-2033 年血液製劑市場報告（按產品、抗血栓和抗凝血劑類型、抗血栓和抗凝血劑應用和地區分類）

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球血液製劑市場規模達462億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到669億美元，2025-2033年期間的複合年成長率（CAGR）為3.98%。由於慢性病患病率上升、政府訂定改善醫療基礎設施的舉措、公眾意識增強導致捐血量增加、血液處理技術的快速進步以及個性化醫療的日益普及，市場規模正在不斷擴大。

血液製劑市場趨勢：

慢性病盛行率不斷上升

心血管疾病、癌症和糖尿病等慢性病的增多是積極影響血液製劑市場動態的主要因素之一。根據產業研究，美國約有 1.29 億人患有至少一種主要慢性病。這些疾病會導致貧血、凝血障礙和免疫系統缺陷等併發症，需要頻繁輸血、血小板替代療法和血漿治療。例如，根據美國國家血液採集和使用調查 (NBCUS) 報告，2021 年美國輸血量為 10,764,000 單位全血提取和單採紅血球 (RBC)。此外，全球老年人口不斷成長，加劇了輸血需求，因為這些人更容易患慢性疾病和相關併發症，這也促進了該行業的擴張。

政府措施及醫療基礎建設發展介紹

政府推出各種措施來改善醫療基礎設施和確保穩定的血液供應，這擴大了血液製劑市場的規模。政府越來越重視投資於促進捐血、改善血庫設施和提高血液製品整體安全性和可用性的舉措，這推動了市場的成長。例如，印度政府 (GOI) 透過輸血服務，一直支持公共和慈善部門的 1131 個血庫，包括人力、血袋和檢測試劑盒的採購、自願捐血 (VBD) 營的開展以及資訊教育交流 (IEC) 活動。此外，各國政府正在實施嚴格的措施來確保血液製品的品質和安全，這有助於在醫療服務提供者和患者之間建立信任。例如，印度政府為監控血庫而採取的一項措施 e-RaktKosh，是一個整合的血庫管理資訊系統，將所有血庫互連成一個網路。

提高認知，增加捐血量

在全球範圍內，人們對捐血重要性的認知日益加深，捐血人數不斷增加，這推動了血液製劑市場的佔有率成長。據估計，美國每年約有680萬人捐血，採集的全血和紅血球數量達1,360萬單位。此外，政府、非政府組織（NGO）和醫療機構主導公共衛生運動和計劃，向公眾宣傳捐血在拯救生命方面的重要性，也促進了市場的成長。同時，已開發國家和發展中國家對血液製品的需求不斷成長，促使捐血系統更加結構化、組織化，從而確保了血液供應的穩定可靠，這也推動了市場的成長。

血液製劑市場細分：

按產品分類：

  • 全血
    • 紅血球
    • 粒細胞
    • 電漿
    • 血小板
  • 血液成分
    • 全血成分
    • 紅血球壓積
    • 白血球減少的紅血球
    • 冷凍血漿
    • 濃縮血小板
    • 冷沉澱物
  • 血液衍生物

全血佔據大部分市場佔有率

根據血液製劑市場分析，全血因其在各種醫療治療中的廣泛應用而佔據市場主導地位，包括外科手術、創傷護理以及為嚴重貧血或失血患者輸血。此外，全血含有所有必需成分，例如紅血球、白血球、血小板和血漿，使其適用於多種臨床應用。此外，在急診和重症監護環境中對全血的需求不斷成長，加上其在救命手術中的關鍵作用，也推動了市場的成長。

依抗血栓和抗凝血劑類型分解：

  • 血小板聚集抑制劑
    • 糖蛋白抑制劑
    • COX抑制劑
    • ADP拮抗劑
    • 其他
  • 纖溶藥物
    • 組織型纖溶酶原活化劑（TPA）
    • 鏈激酶
    • 尿激酶
  • 抗凝血劑
    • 肝素
    • 維生素K拮抗劑
    • 直接凝血酶抑制劑
    • 直接Xa因子抑制劑

抗凝血劑佔產業最大佔有率

根據血液製劑市場概況，抗凝血劑佔據了最大的市場佔有率，這得益於其在預防和治療血栓方面的關鍵作用，而血栓在深部靜脈栓塞、肺栓塞和心房顫動等疾病中很常見。此外，抗凝血劑對於治療血栓相關疾病以及降低中風和心臟病發作的風險至關重要。此外，抗凝血劑在外科手術和心血管疾病患者的長期治療中的頻繁使用也促進了市場的成長。此外，老年人口的不斷成長（老年人更容易患上凝血障礙）以及安全性和有效性更高的新型抗凝血劑療法的開發，正在推動血液製劑市場的成長率。

抗血栓和抗凝血劑的分解應用：

  • 血小板增多症
  • 肺栓塞
  • 腎功能不全
  • 心絞痛血管併發症
  • 其他

血小板增多症是領先的細分市場

根據血液製劑市場預測，血小板增多症佔據了最大的市場佔有率，這是由於導致血小板計數升高的疾病（例如骨髓增生性疾病）的盛行率不斷上升。此外，血小板增多症常導致過多的血栓形成，進而引發中風或心臟病等嚴重併發症。抗凝血劑和抗血栓治療對於預防異常凝血至關重要。此外，人們對血小板增多症認知的不斷提高、診斷工具的快速進步以及標靶抗凝血治療的普及，正在推動市場的成長。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美領先市場，佔據最大血液製劑市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是血液製劑最大的區域市場。

根據血液製劑市場報告，北美地區憑藉其完善的醫療基礎設施、高發生率的慢性病和龐大的醫療支出，佔據了市場領先地位。此外，癌症、心血管疾病和貧血等需要定期輸血和血小板治療的疾病發生率不斷上升，導致血液製品需求不斷成長，這也推動了市場的成長。此外，先進醫療技術的引入、對血液安全的高度重視以及該地區龐大的捐血中心網路，也是血液製劑市場的主要驅動力。

（請注意，這只是關鍵參與者的部分名單，完整名單將在報告中提供。）

  • 市場領導者正專注於策略合作、產品創新和地理擴張，以鞏固其市場地位。他們正在投資研發，引進先進的血液製品和技術，以提高安全性和有效性。此外，一些公司正在提升生產能力，以滿足日益成長的血漿衍生療法和其他血液成分的需求。此外，他們還與醫院、血庫和醫療機構建立合作夥伴關係，以確保穩定的供應鏈並提高可及性。

本報告回答的關鍵問題

  • 2024年全球血液製劑市場規模為多少
  • 2025-2033年全球血液製劑市場的預期成長率是多少
  • 推動全球血液製劑市場的關鍵因素有哪些
  • COVID-19 對全球血液製劑市場有何影響
  • 根據產品類型，全球血液製劑市場如何分類？
  • 根據抗血栓和抗凝血劑類型，全球血液製劑市場如何分類
  • 根據抗血栓和抗凝血劑的應用，全球血液製劑市場如何分佈
  • 全球血液製劑市場重點區域有哪些
  • 全球血液製劑市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球血液製劑市場規模？ 2025-2033年全球血液製劑市場的預期成長率是多少？
  • 推動全球血液製劑市場發展的關鍵因素有哪些？
  • COVID-19 對全球血液製劑市場有何影響？
  • 根據產品，全球血液製劑市場是如何分佈的？
  • 根據抗血栓和抗凝血劑類型，全球血液製劑市場是如何分佈的？
  • 根據抗血栓和抗凝血劑的應用，全球血液製劑市場是如何分佈的？
  • 全球血液製劑市場的主要區域有哪些？
  • 全球血液製劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球血液製劑市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 全血
    • 關鍵部分
      • 紅血球
      • 粒細胞
      • 電漿
      • 血小板
  • 血液成分
    • 關鍵部分
      • 全血成分
      • 紅血球壓積
      • 白血球減少的紅血球
      • 冷凍血漿
      • 濃縮血小板
      • 冷沉澱物
  • 血液衍生物

第7章：市場區隔：按抗血栓和抗凝血劑類型

  • 血小板聚集抑制劑
    • 關鍵部分
      • 糖蛋白抑制劑
      • COX抑制劑
      • ADP拮抗劑
      • 其他
  • 纖溶藥物
    • 關鍵部分
      • 組織型纖溶酶原活化劑（TPA）
      • 鏈激酶
      • 尿激酶
  • 抗凝血劑
    • 關鍵部分
      • 肝素
      • 維生素K拮抗劑
      • 直接凝血酶抑制劑
      • 直接Xa因子抑制劑

第 8 章：市場區隔：按抗血栓和抗凝血劑的應用

  • 血小板增多症
  • 肺栓塞
  • 腎功能不全
  • 心絞痛血管併發症
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
    • Sanofi SA
Product Code: SR112025A4552

The global blood preparation market size reached USD 46.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 66.9 Billion by 2033, exhibiting a growth rate (CAGR) of 3.98% during 2025-2033. The market is expanding due to the rising prevalence of chronic diseases, imposition of government initiatives that improve healthcare infrastructure, growing public awareness leading to increased blood donations, rapid advancements in blood processing technology, and the increasing adoption of personalized medicine.

Blood Preparation Market Trends:

Increasing Prevalence of Chronic Diseases

The rise in chronic diseases, including cardiovascular conditions, cancer, and diabetes, is one of the major factors positively impacting the blood preparation market dynamics. As per industry research, an estimated 129 million people in the U.S. have at least one major chronic disease. These diseases are known to result in complications such as anemia, clotting disorders, and immune system deficiencies, which require frequent blood transfusions, platelet replacement therapy, and plasma treatments. For instance, according to the National Blood Collection and Utilization Survey (NBCUS) report, in 2021, 10,764,000 units of whole blood-derived and apheresis red blood cells (RBCs) were transfused in the United States. Moreover, the growing geriatric population across the globe, exacerbating the need for blood transfusion as these individuals are more prone to chronic illnesses and associated complications, is bolstering the expansion of this industry.

Introduction of Government Initiatives and Healthcare Infrastructure Development

The introduction of various government initiatives to improve healthcare infrastructure and ensure a stable blood supply is enhancing the blood preparation market size. The increasing government focus on investing in initiatives that promote blood donation, improve blood bank facilities, and enhance the overall safety and availability of blood products is boosting the market growth. For instance, the Government of India (GOI), through blood transfusion services, has been supporting 1131 blood banks in the public and charitable sector with respect to manpower, procurement of blood bags and testing kits, conduction of voluntary blood donation (VBD) camps, and information education communication (IEC) activities. In addition, governments are implementing stringent measures to ensure the quality and safety of blood products, which helps build trust among healthcare providers and patients. For example, e-RaktKosh, an initiative of the Government of India to monitor the blood banks, is an integrated blood bank management information system that interconnects all the blood banks into a single network.

Growing Awareness and Increasing Blood Donations

The growing awareness about the importance of blood donation and the increasing number of blood donors across the globe are boosting the blood preparation market share. Each year, an estimated 6.8 million people in the U.S. donate blood, and 13.6 million units of whole blood and red blood cells are collected. Moreover, the introduction of public health campaigns and initiatives led by governments, non-governmental organizations (NGOs), and healthcare providers to educate the public about the life-saving importance of donating blood is bolstering the market growth. Along with this, the growing demand for blood products in developed and developing countries that is leading to more structured and organized blood donation systems, which ensure a steady and reliable supply of blood, is fueling the market growth.

Blood Preparation Market Segmentation:

Breakup by Product:

  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
    • Cryoprecipitate
  • Blood Derivatives

Whole blood accounts for the majority of the market share

As per the blood preparation market analysis, whole blood dominated the market due to its widespread use in various medical treatments, including surgeries, trauma care, and transfusions for patients with severe anemia or blood loss. Moreover, it contains all essential components, such as red cells, white cells, platelets, and plasma, making it versatile for multiple clinical applications. Besides this, the growing demand for whole blood in emergency and critical care settings, coupled with its crucial role in life-saving procedures, is contributing to the market growth.

Breakup by Antithrombotic and Anticoagulants Type:

  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • COX Inhibitors
    • ADP Antagonists
    • Others
  • Fibrinolytics
    • Tissue Plasminogen Activator (TPA)
    • Streptokinase
    • Urokinase
  • Anticoagulants
    • Heparins
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors

Anticoagulants holds the largest share of the industry

Based on the blood preparation market overview, anticoagulants accounted for the largest market, driven by their critical role in preventing and treating blood clots, which are common in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation. Moreover, anticoagulants are essential for managing clot-related disorders and reducing the risk of strokes and heart attacks. Besides this, their frequent use in surgical procedures and long-term treatments for patients with cardiovascular conditions is enhancing the market growth. Along with this, the increasing geriatric population, which is more prone to clotting disorders, and the development of newer anticoagulant therapies that offer improved safety and efficacy profiles are boosting the blood preparation market growth rate.

Breakup by Antithrombotic and Anticoagulants Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Thrombocytosis represents the leading market segment

According to the blood preparation market forecast, thrombocytosis represented the largest share in the market, due to the increasing prevalence of conditions that cause elevated platelet counts, such as myeloproliferative disorders. Moreover, thrombocytosis often leads to excessive blood clot formation, which can result in severe complications like strokes or heart attacks. Anticoagulants and antithrombotic therapies are critical for managing this condition by preventing abnormal clotting. Along with this, the growing awareness of thrombocytosis, rapid advancements in diagnostic tools, and the availability of targeted anticoagulant treatments are driving the market growth.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest blood preparation market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for blood preparation.

As per the blood preparation market report, North America is leading the market, driven by its well-established healthcare infrastructure, high prevalence of chronic diseases, and significant healthcare spending. Moreover, the growing demand for blood products, fueled by the growing incidence of conditions such as cancer, cardiovascular diseases, and anemia, which require regular blood transfusions and platelet therapies, is bolstering the market growth. Besides this, the introduction of advanced medical technologies, a strong emphasis on blood safety, and a large network of blood donation centers in the region are acting as major blood preparation market drivers.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the blood preparation industry include Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.), Sanofi S.A., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The leading players in the market are focusing on strategic collaborations, product innovations, and expanding their geographical presence to strengthen their market positions. They are investing in research and development (R&D) to introduce advanced blood products and technologies aimed at improving safety and efficacy. Moreover, several firms are enhancing their production capabilities to meet the rising demand for plasma-derived therapies and other blood components. Besides this, they are forming partnerships with hospitals, blood banks, and healthcare institutions to secure stable supply chains and improve accessibility.

Key Questions Answered in This Report

  • 1.What was the size of the global blood preparation market in 2024?
  • 2.What is the expected growth rate of the global blood preparation market during 2025-2033?
  • 3.What are the key factors driving the global blood preparation market?
  • 4.What has been the impact of COVID-19 on the global blood preparation market?
  • 5.What is the breakup of the global blood preparation market based on the product?
  • 6.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8.What are the key regions in the global blood preparation market?
  • 9.Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2024
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2024
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million USD), 2025-2033
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million USD), 2025-2033
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players